
Opinion|Videos|March 21, 2025
Maria's Patient Journey: Impact of Support Systems
Author(s)Arash Mostaghimi, MD, MPH, Brett King, MD, PhD
A panelist discusses how finding an effective treatment for their condition has dramatically improved their mental health and quality of life by restoring their confidence and reducing anxiety about their appearance, allowing them to participate more fully in social activities and giving them a renewed sense of hope and normalcy.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How do you feel your mental health and quality of life have improved now that you have found an effective treatment?
Advertisement
Related to this article

The FDA updated the risankizumab label to make pretreatment TB evaluation a matter of clinical judgment across all indications, including psoriasis.

Phase 2 and 3 data show difamilast 1% ointment improved severity and itch within 1 week in adults and children with mild to moderate atopic dermatitis.

Final VALUE data show fewer drug changes with risankizumab vs other biologics over 37 months in patients with psoriasis and comorbid psoriatic arthritis.

Stay updated with the latest healthcare breakthroughs, including new TRANSCEND-T2D-2 data and FDA actions.

The plasmid DNA immunotherapy Voceryq gained FDA accelerated approval after 27% of RRP-001 patients needed no surgery for 12 months.

IgAN late-breakers led the meeting, alongside new data on aspirin, dialysis access, donor pregnancy, potassium, and depression.

Experts discuss remibrutinib, the first FDA-approved therapy for symptomatic dermographism: RemIND data, bleeding counseling, and where it fits in practice
Advertisement
Advertisement
Trending on HCPLive
1
Cardiac Health Indicators Improve Following CCM Implantation in Heart Failure
2
Sarcoidosis Care Starts With Inflammation vs Fibrosis: Rohit Gupta, MD
3
ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know
4
HCPLive Five at CHEST 2026
5

